Publications by authors named "Richard Ratei"

Claim this Profile
A
Automated identification of cell populations in flow cytometry data with transformers.
Matthias Wödlinger, Michael Reiter, Lisa Weijler, Margarita Maurer-Granofszky, Angela Schumich, Richard Ratei

Comput Biol Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report.
Margarita Maurer-Granofszky, Angela Schumich, Barbara Buldini, Giuseppe Gaipa, Janos Kappelmayer, Richard Ratei

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Loss-of-function uORF mutations in human malignancies.
Julia Schulz, Nancy Mah, Martin Neuenschwander, Tabea Kischka, Richard Ratei

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcome of IG-MYC neoplasms with precursor B-cell phenotype in childhood and adolescence.
Heidi Herbrueggen, Stephanie Mueller, Jonas Rohde, Laura Arias Padilla, Anja Moericke, Richard Ratei

Leukemia· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Flow Cytometric MRD Assessment in Childhood Acute B- Lymphoblastic Leukemia Using Supervised Machine Learning.
Michael Reiter, Markus Diem, Angela Schumich, Margarita Maurer-Granofszky, Leonid Karawajew, Richard Ratei

Cytometry A· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
Angela Schumich, Margarita Maurer-Granofszky, Andishe Attarbaschi, Ulrike Pötschger, Barbara Buldini, Richard Ratei

Pediatr Blood Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.
Stephan Fuhrmann, Richard Schabath, Anja Möricke, Martin Zimmermann, Joachim B Kunz, Richard Ratei

Br J Haematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
Ondrej Hrusak, Valerie de Haas, Jitka Stancikova, Barbora Vakrmanova, Iveta Janotova, Richard Ratei

Blood· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss-of-function uORF mutations in human malignancies.
Julia Schulz, Nancy Mah, Martin Neuenschwander, Tabea Kischka, Richard Ratei

Sci Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia.
Michael N Dworzak, Barbara Buldini, Giuseppe Gaipa, Richard Ratei, Ondrej Hrusak

Cytometry B Clin Cytom· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Eva Landmann, Birgit Burkhardt, Martin Zimmermann, Ulrike Meyer, Wilhelm Woessmann, Richard Ratei

Haematologica· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation, alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.
Jana Hof, Corinne Kox, Stefanie Groeneveld-Krentz, Obul R Bandapalli, Leonid Karawajew, Richard Ratei

Haematologica· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Flow-cytometric immunophenotyping in clinical diagnostics].
Benjamin Nils Ostendorf, Leo Hansmann, Wolf-Dieter Ludwig, Bernd Dörken, Richard Ratei

Dtsch Med Wochenschr· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
Anja Möricke, Martin Zimmermann, Maria Grazia Valsecchi, Martin Stanulla, Andrea Biondi, Richard Ratei

Blood· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms.
Nadine Kutsch, Reinhard Marks, Richard Ratei, Thomas K Held, Martin Schmidt-Hieber

Biomark Insights· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Leonid Karawajew, Michael Dworzak, Richard Ratei, Peter Rhein, Giuseppe Gaipa

Haematologica· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow diagnostics essential code: a simple and brief format for the summary of leukemia phenotyping.
Ondřej Hrušák, Giuseppe Basso, Richard Ratei, Giuseppe Gaipa, Drorit Luria

Cytometry B Clin Cytom· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
Anju Singh, Richard Schabath, Richard Ratei, Andrea Stroux, Claus-Detlev Klemke

Hematol Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Gunnar Cario, Peter Rhein, Rita Mitlöhner, Martin Zimmermann, Obul R Bandapalli, Richard Ratei

Haematologica· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Petra Dörge, Barbara Meissner, Martin Zimmermann, Anja Möricke, André Schrauder, Richard Ratei

Haematologica· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia.
Giuseppe Gaipa, Giovanni Cazzaniga, Maria Grazia Valsecchi, Renate Panzer-Grümayer, Barbara Buldini, Richard Ratei

Haematologica· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome.
Lutz Zeidler, Martin Zimmermann, Anja Möricke, Barbara Meissner, Dorothee Bartels, Richard Ratei

Haematologica· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation.
Nicola Gökbuget, Nadezda Basara, Herrad Baurmann, Joachim Beck, Monika Brüggemann, Richard Ratei

Blood· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study.
Martin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, André Schrauder, Renate Panzer-Grümayer, Richard Ratei

Blood· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.
Richard Ratei, Michael Hummel, Ioannis Anagnostopoulos, Doris Jähne, Renate Arnold

Haematologica· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis